Evidence map›Paper›PMID 11040218›Full record

ArticleGenes & development2000

Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters.

L Schramm, P S Pendergrast, Y Sun, N Hernandez

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Reply to Schramm, L. Comment on "Li et al.Diagnostics (Basel, Switzerland) · 2022
    Article
  13. Comment on Li et al.Diagnostics (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. RNA Polymerase III Subunit Mutations in Genetic Diseases.Frontiers in molecular biosciences · 2021
    Review
  18. Article
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

L SchrammDepartment of Pharmacology, State University of New York at Stony Brook, Stony Brook, New York 11794, USA.
P S Pendergrast
Y Sun
N Hernandez
Cold Spring Harbor Laboratory · USHoward Hughes Medical Institute · US

Funding

EXPRESSION OF SNRNA GENESR01GM038810 · NIGMS · COLD SPRING HARBOR LABORATORY · PI STENLUND, ARNE · 1987 to 2006
$1.5M
NIGMS NIH HHS GM38810NIGMS NIH HHS R01 GM038810
6 · The paper itself

Abstract

Transcription initiation at RNA polymerase III promoters requires transcription factor IIIB (TFIIIB), an activity that binds to RNA polymerase III promoters, generally through protein-protein contacts with DNA binding factors, and directly recruits RNA polymerase III. Saccharomyces cerevisiae TFIIIB is a complex of three subunits, TBP, the TFIIB-related factor BRF, and the more loosely associated polypeptide beta("). Although human homologs for two of the TFIIIB subunits, the TATA box-binding protein TBP and the TFIIB-related factor BRF, have been characterized, a human homolog of yeast B(") has not been described. Moreover, human BRF, unlike yeast BRF, is not universally required for RNA polymerase III transcription. In particular, it is not involved in transcription from the small nuclear RNA (snRNA)-type, TATA-containing, RNA polymerase III promoters. Here, we characterize two novel activities, a human homolog of yeast B("), which is required for transcription of both TATA-less and snRNA-type RNA polymerase III promoters, and a factor equally related to human BRF and TFIIB, designated BRFU, which is specifically required for transcription of snRNA-type RNA polymerase III promoters. Together, these results contribute to the definition of the basal RNA polymerase III transcription machinery and show that two types of TFIIIB activities, with specificities for different classes of RNA polymerase III promoters, have evolved in human cells.

Indexed as

Transcription, GeneticAmino Acid SequenceCloning, MolecularHumansMolecular Sequence DataPromoter Regions, GeneticRibonucleoprotein, U4-U6 Small NuclearRNA Polymerase IIIRNA, ViralSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSequence Homology, Amino AcidTATA-Binding Protein Associated FactorsTATA BoxTranscription FactorsTranscription Factor TFIIIBadenovirus associated RNABRF1 protein, humanBRF1 protein, S cerevisiaeBRF2 protein, humanRibonucleoprotein, U4-U6 Small NuclearRNA Polymerase IIIRNA, ViralSaccharomyces cerevisiae ProteinsTATA-Binding Protein Associated FactorsTranscription FactorsTranscription Factor TFIIIB

Identifiers

PMID11040218
PMCPMC316990
OpenAlexW2059198116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.